BioSpace News Archive

Pharm Country

RH Nanopharmacuticals, LLC Receives NIH HEAL Grant To Develop And Test Intravenous Micronized Salsalate As A Safer Alternative To Opioids For Acute Post Operative Pain Management

RH Nanopharmaceuticals, LLC is pleased to announce that it has been awarded the National Institute of Health – HEAL award effective September 26, 2019.

September 27, 2019
·
2 min read
Policy

AVEDRO, INC. SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces an Investigation of Avedro, Inc. (AVDR) Over the Proposed Merger of the Company with Glaukos Corporation

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating the proposed merger of Avedro, Inc. with Glaukos Corporation.

September 27, 2019
·
2 min read
Drug Development

Cellular Biomedicine Group’s ReJoin® Therapy Receives Stem Cell Drug Application Acceptance For Phase II Clinical Trials by China NMPA

Cellular Biomedicine Group, Inc. announced that a drug application* for its off-the-shelf autologous adipose-derived mesenchymal progenitor cell ReJoin® therapy for Knee Osteoarthritis has been accepted for a Phase II clinical trial in China.

September 27, 2019
·
6 min read
FDA

Expanded Approval for AbbVie’s Mayvret Shortens Treatment Time for Some HCV Patients

AbbVie’s Mayvret won expanded approval from the U.S. Food and Drug Administration to shorten the one-daily treatment duration from 12 to eight weeks in treatment-naïve hepatitis C patients without cirrhosis and with compensated cirrhosis.

September 27, 2019
·
2 min read
·
Alex Keown
Drug Development

Pfizer’s Atopic Dermatitis Drug Hits the Mark in Second Phase III Trial

Pfizer announced positive top-line results from the first trial in May.

September 27, 2019
·
2 min read
·
Alex Keown
FDA

FDA Approves Darzalex for New Multiple Myeloma Indication

The FDA’s latest approval for Darzalex is based on results from the Phase III CASSIOPEIA trial that showed the addition of Darzalex to VTd before and after ASCT resulted in deeper responses in patients with the blood cancer.

September 27, 2019
·
3 min read
·
Alex Keown
Business

After 40 Years with Pfizer, Ian Read Will Step Down as Chairman of the Board

Current Chief Executive Officer Albert Bourla will succeed Read as chairman on Jan. 1, 2020 and will continue to serve as CEO.

September 27, 2019
·
2 min read
·
Alex Keown
Genetown

Transportation Woes Have Bay State Workers Eying Other Jobs to Curb Commute Times: Survey

The Massachusetts Biotechnology Council recently released a 2019 transportation survey for the Bay State that shows 60% of respondents would change jobs for a better commute.

September 27, 2019
·
2 min read
·
Alex Keown